Issues & Perspectives

A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet

A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet

Posted by  | Issues & Perspectives, Patient Stories, Prevention/Screening, Research, treatment

Read the latest issue of Promise & Progress featuring research advances in cancer drug discovery and development, promising new cancer drugs, patient stories and more. From scientific meetings to our own dinner tables, conversations about better treatments for cancer are among the most frequently discussed health care topics. Everyone wants them—the doctors and scientists who(...)

Pancreatic Cancer Awareness Month

Pancreatic Cancer Awareness Month

Posted by  | Issues & Perspectives, treatment

It’s Pancreatic Cancer Awareness Month, so we wanted to gather our best Kimmel Cancer Center resources for you. Learn more about cancer vaccines and other ways our experts are working to get the immune system to fight pancreatic cancer. Watch leading pancreatic cancer and immunology expert Elizabeth Jaffee, M.D., talk about new work from our(...)

Do you qualify for Social Security disability as a cancer patient? 5 tests

Posted by  | caregiving, Issues & Perspectives, treatment, Uncategorized

Social Security pays benefits for a medical condition that is expected to last for at least a year, or may result in death.  Supplemental Security Income (SSI) supports the aged, blind or disabled who have little or no income, providing cash for basics like food, clothing and shelter. According to social workers at the Johns Hopkins(...)

Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics

Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics

Posted by  | Issues & Perspectives

Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30 years of basic research at Johns Hopkins and its Bloomberg~Kimmel Institute, pembroluzimab now can be used for colon, pancreatic, stomach, ovarian and other cancers if genetic testing reveals defects in(...)

Lung cancer immunotherapy options expand

Lung cancer immunotherapy options expand

Posted by  | Issues & Perspectives

Patients and doctors received news this week of the FDA’s approval of the immunotherapy drug pembrolizumab in combination with platinum doublet chemotherapy as first-line therapy for all patients with non-small cell lung cancer, irrespective of patients’ tumor PD-L1 status. The new approval follows the FDA’s decision last November to approve pembrolizumab as a first-line therapy for some(...)

Kimmel Cancer Center Joins Nation’s Cancer Centers in Supporting HPV Vaccination

Posted by  | Issues & Perspectives

The Johns Hopkins Kimmel Cancer Center joined all of the nation's cancer centers designated by the National Cancer Institute in endorsing human papillomavirus (HPV) vaccination to prevent cancers caused by the ubiquitous virus. HPV infections are known to cause most cervical, anal, oropharyngeal and other genital cancers. Vaccines are available to prevent infections of certain(...)